GEN Exclusives

More »

GEN News Highlights

More »
Jan 10, 2012

U.K.’s Technology Strategy Board Awards £900K to Stem Cell Research Consortium

  • The U.K.’s Technology Strategy Board has awarded £900,000 ($1.39 million) toward a £1.4 million ($2.17 million) research consortium that will work to develop methods of characterizing stem cells through protein fingerprints predictive of changes in stem cell behavior. The consortium will be led by Cellzome, with members that include Plasticell, the University of Sheffield, and Neusentis, Pfizer’s U.K.-based pain, sensory disorders, and regenerative medicine research unit.

    The research will address a critical issue in human stem cell research, with downstream applications in regenerative medicine and cellular therapies,” remarks Dennis Saw, CEO of Plasticell.

    The Technology Strategy Board is a business-led government body sponsored by the Department for Business, Innovation and Skills, and created to ensure U.K. global leadership in innovation by supporting projects deemed to create economic growth.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?